10.1038/npp.2016.158 [DOI] [PMC free article] [PubMed] [Google Scholar] 38.de Cossio L, Guzman A, van der Veldt S, Luheshi G
Chen Z, Gao XD, Li Z (2022) Recent advances regarding the physiological functions and biosynthesis of D-allulose
Blood sugar control and metabolic benefits Both CagriSema and tirzepatide produce substantial improvements in glycemic markers, but the mechanisms driving these improvements differ, and the magnitude varies between populations

Clinical considerations for specific populations: Individuals with diabetes should consult their GP or diabetes specialist before making significant dietary changes, as alterations in carbohydrate intake and meal timing may affect blood glucose control and medication requirements Those taking insulin or sulfonylureas should be particularly cautious, as dietary changes may increase the risk of hypoglycaemia [15] [16] Those with kidney disease should seek medical advice before substantially increasing protein intake People with digestive disorders (such as irritable bowel syndrome) may need to modify fibre recommendations based on individual tolerance Seek urgent medical attention for severe abdominal pain (especially if radiating to the back), persistent vomiting, blood in stool, or symptoms of hypoglycaemia or hyperglycaemia
Laborc for assistance with the metabolic cage experiments
Combining all three covers the most-referenced regenerative-research formulation in a single vial